Controversy revisited: selective serotonin reuptake inhibitors in paediatric depression

References

• Aursnes I, Tvete IF, Gaasemyr J, Natvig B. Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Med 2005; 3: 14
   PubMedGoogle Scholar
• Beasley CM, Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH, Jr, Heiligenstein JH, et al. Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression. Br Med J 1991; 303: 685–692
   PubMed Web of Science ®Google Scholar
• Berk M, Dodd S. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?. Med Hypotheses 2005; 65: 39–43
   PubMed Web of Science ®Google Scholar
• Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170: 477–480
   PubMed Web of Science ®Google Scholar
• Chan A-W, Hrsbjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. J Am Med Assoc 2004; 291: 2457–2465
   PubMed Web of Science ®Google Scholar
• Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005; 46: 735–754
   PubMed Web of Science ®Google Scholar
• Clarke G, Debar L, Lynch F, Powell J, Gale J, O'Connor E, et al. A randomized effectiveness trial of brief cognitive-behavioural therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry 2005; 44: 888–898
   PubMed Web of Science ®Google Scholar
• Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry 2004; 65: 742–749
   PubMed Web of Science ®Google Scholar
• DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409–416
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, McCracken JT, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004; 43: 1397–1405
   PubMed Web of Science ®Google Scholar
• Fergusson, D, Doucette, S, Glass, KC, Shapiro, S, Healy, D, Hebert, P, Hutton, B. 2005. Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. Br Med J, 330:396–399, [Erratum in 330:653].
   PubMed Web of Science ®Google Scholar
• Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2004; 43: 1387–1396
   PubMed Web of Science ®Google Scholar
• Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. Br Med J 2005; 330: 385–388
   PubMed Web of Science ®Google Scholar
• Harrington R, Whittaker J, Shoebridge P, Campbell F. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. Br Med J 1998; 316: 1559–1563
   PubMed Web of Science ®Google Scholar
• Holtmann, M, Bolte, S, Poustka, F. 2005. Suicidality in depressive children and adolescents during treatment with selective serotonin reuptake inhibitors. Review and meta-analysis of the available randomised, placebo controlled trials. Nervenarzt June 29 [Epub ahead of print].
   Google Scholar
• Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: A controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand 2005; 111: 286–290
   PubMed Web of Science ®Google Scholar
• Jain, R. Single-action versus dual-action antidepressants. 2004. Prim Care Companion, J Clin Psychiatry, 6((Suppl 1)):7–11.
   Google Scholar
• Jick H, Ulcickas M, Dean A. Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone. Pharmacotherapy 1992; 12: 451–454
   PubMedGoogle Scholar
• Jick SS, Dean AD, Jick H. Antidepressants and suicide. Br Med J 1995; 310: 215–218
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. J Am Med Assoc 2004; 292: 338–342
   PubMed Web of Science ®Google Scholar
• Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. Br Med J 2004; 328: 879–883
   PubMed Web of Science ®Google Scholar
• Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry 2003; 160: 790–792
   PubMed Web of Science ®Google Scholar
• Leon AC, Marzuk PM, Tardiff K, Teres JJ. Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. J Clin Psychiatry 2004; 65: 915–918
   PubMedGoogle Scholar
• March, J, Silva, S, Petrycki, S, Curry, J, Wells, K, Fairbank, J, for the Treatment for Adolescents With Depression Study (TADS) Team, et al. 2004. Fluoxetine, cognitive–behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. J Am Med Assoc, 292:807–820.
   PubMed Web of Science ®Google Scholar
• Nilsson M, Joliat MJ, Miner CM, Brown EB, Heiligenstein JH. Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents. J Child Adolesc Psychopharmacol 2004; 14: 412–417
   PubMed Web of Science ®Google Scholar
• Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60: 978–982
   PubMed Web of Science ®Google Scholar
• Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression. Arch Gen Psychiatry 2004; 61: 714–719
   PubMed Web of Science ®Google Scholar
• Papanikolaou, K, Richardson, C, Pehlivanidis, A, Papadopoulou-Daifoti, Z. 2005. Efficacy of antidepressants in child and adolescent depression: A meta-analytic study. J Neural Transm, 3, [Epub ahead of print].
   Google Scholar
• Pediatric OCD Treatment Study (POTS) Team. 2004. The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Cognitive–behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. J Am Med Assoc, 292:1969–1976.
   PubMed Web of Science ®Google Scholar
• Richmond TK, Rosen DS. The treatment of adolescent depression in the era of the black box warning. Curr Opin Pediatr 2005; 17: 466–472
   PubMedGoogle Scholar
• Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147: 207–210
   PubMed Web of Science ®Google Scholar
• Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: A propensity-adjusted retrospective cohort study. CNS Drugs 2004; 18: 1119–1132
   PubMed Web of Science ®Google Scholar
• Vitiello B, Swedo S. Antidepressant medications in children. New Engl J Med 2004; 350: 1489–1491
   PubMed Web of Science ®Google Scholar
• Wagner, KD, Ambrosini, P, Rynn, M, Wohlberg, C, Yang, R, Greenbaum, MS, for the Sertraline Pediatric Depression Study Group, et al. 2003. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. J Am Med Assoc, 290:1033–1041.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004; 161: 1079–1083
   PubMed Web of Science ®Google Scholar
• Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry 2004; 61: 1153–1162
   PubMed Web of Science ®Google Scholar
• Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005; 146: 685–693
   PubMed Web of Science ®Google Scholar
• Weiss JJ, Gorman JM. Antidepressant adherence and suicide risk in depressed youth. Am J Psychiatry 2005; 162: 1756–1757
   PubMed Web of Science ®Google Scholar
• Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 2004; 363: 1341–1345
   PubMed Web of Science ®Google Scholar